BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 27
• 28
• 29
• 30

• Policy

  Orthovita, Inc. Submits PMA To FDA For Approval To Transfer Commercial Manufacturing Of VITAGEL(TM) Surgical Hemostat Product To Its Malvern Facility

  December 5, 2005

   · 

  1 min read
• Drug Development

  OXiGENE To Commence First Ever Oncology Clinical Trial Combining A Vascular Disrupting Compound, Combretastatin A4P, With An Anti-Angiogenic Agent, Avastin

  December 5, 2005

   · 

  8 min read
• Medical Services International Inc. Completes Tuberculosis (TB) Testing In Republic Of Ukraine

  December 5, 2005

   · 

  2 min read
• Biotech Bay

  Gilead Sciences (Foster City, CA) To Present At The NASDAQ 16th Investor Program

  December 5, 2005

   · 

  1 min read
• Policy

  Provost Umphrey, LLP Files Securities Fraud Class Action Against Guidant Corporation

  December 5, 2005

   · 

  1 min read
• Policy

  FDA Committee Backs Noven Pharmaceuticals Inc.'s And Shire Pharmaceuticals’ Skin Patch For Hyperactivity In Children

  December 5, 2005

   · 

  1 min read
• FDA

  Par Pharmaceutical Companies, Inc.'s Partner Receives Final Approval To Market Ribavirin Tablets

  December 5, 2005

   · 

  2 min read
• Biotech Beach

  MediciNova, Inc. Announces Share Repurchase Program

  December 5, 2005

   · 

  2 min read
• Drug Development

  Spectrum Pharmaceuticals, Inc. Announces Achievement Of Target Enrollment In Satraplatin Phase 3 Registrational Trial (SPARC) For Second-Line Chemotherapy Of Hormone Refractory Prostate Cancer

  December 5, 2005

   · 

  6 min read
• Biotech Bay

  SuperGen, Inc. To Present At First Albany Capital Annual Growth Conference

  December 5, 2005

   · 

  1 min read